GALT•benzinga•
Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday?
Summary
Galectin Therapeutics' NAVIGATE trial shows belapectin reduces varices in MASH cirrhosis, but falls short of statistical targets; full data due in early 2025.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 20, 2024 by benzinga